Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2013 Nov 14;37(6):499–504. doi: 10.1111/j.1348-0421.1993.tb03242.x

Enhancement and Neutralization of Feline Infectious Peritonitis Virus Infection in Feline Macrophages by Neutralizing Monoclonal Antibodies Recognizing Different Epitopes

Tsutomu Hohdatsu 1,, Hitomi Yamada 1, Yuzuru Ishizuka 1, Hiroyuki Koyama 1
PMCID: PMC7168507  PMID: 7694052

Abstract

The interaction between the enhancing and neutralizing activities of three monoclonal antibodies (MAbs) (5‐6‐2, 6‐4‐2 and 7‐4‐1) to the spike protein of feline infectious peritonitis virus (FIPV) strain 79‐1146 was determined using feline macrophages. At a high MAb concentration, all of the three MAbs completely inhibited the FIPV infection at 37 C. However, two of them (6‐4‐2 and 7‐4‐1) enhanced FIPV infection when either the MAb concentration or reaction temperature was lowered. These MAbs also exerted an immediate infectivity‐enhancing activity for up to 10 min of reaction and by 20 min, neutralizing activities were observed. Only MAb 5‐6‐2 consistently showed neutralizing activity regardless of the reaction conditions. Competition with sera from cats experimentally infected with FIPV strain 79‐1146 or feline enteric coronavirus strain 79‐1683 showed that the two epitopes recognized by MAb 5‐6‐2 and MAb 6‐4‐2, respectively, are also recognized by the natural host.

Keywords: antibody‐dependent enhancement, monoclonal antibody, feline infectious peritonitis virus


Abbreviations

ADE

antibody‐dependent enahancement

CrFK

Crandell feline kidney

ELISA

enzyme‐linked immunosorbent assay

fcwf‐4

feline whole fetus cells

FECV

feline enteric coronavirus

FIPV

feline infectious peritonitis virus

HBSS

Hanks' balanced salt solution

IFA

indirect fluorescent antibody assay

MAb

monoclonal antibody

MAbs

monoclonal antibodies

M protein

transmembrane protein

NT test

neutralization test

PBS

phosphate‐buffered saline solution

RS virus

respiratory syncytial virus

S protein

peplomer spike protein

TCID50

50% tissue culture infectious dose.

References

  • 1. Chanas, A.C. , Gould, E.A. , Clegg, J.C.S. , and Varma, M.G.R. 1982. Monoclonal antibodies to Sindbis virus glycoprotein El can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J. Gen. Virol. 58: 37–46. [DOI] [PubMed] [Google Scholar]
  • 2. Corapi, W.V. , Olsen, C.W. , and Scott, F.W. 1992. Monoclonal antibody analysis of neutralization and antibody‐dependent enhancement of feline infectious peritonitis virus. J. Virol. 66: 6695–6705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gimenez, H.B. , Keir, H.M. , and Cash, P. 1989. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. J. Gen. Virol. 70: 89–96. [DOI] [PubMed] [Google Scholar]
  • 4. Halstead, S.B. , and O'Rourke, E.J. 1977. Antibody‐enhanced dengue virus infection in primate leukocytes. Nature 265: 739–741. [DOI] [PubMed] [Google Scholar]
  • 5. Halstead, S.B. , and O'Rourke, E.J. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by nonneutralizing antibody. J. Exp. Med. 146: 201–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Halstead, S.B. , Venkateshan, C.N. , Gentry, M.K. , and Larsen, L.K. 1984. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 132: 1529–1532. [PubMed] [Google Scholar]
  • 7. Halstead, S.B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239: 476–481. [DOI] [PubMed] [Google Scholar]
  • 8. Hayashi, T. , Goto, N. , Takahashi, R. , and Fujiwara, K. 1978. Detection of coronavirus‐like particles in a spontaneous case of feline infectious peritonitis. Jpn. J. Vet. Sci. 40: 207–212. [DOI] [PubMed] [Google Scholar]
  • 9. Hohdatsu, T. , Okada, S. , and Koyama, H. 1991. Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine and canine coronaviruses. Arch. Virol. 117: 85–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Hohdatsu, T. , Nakamura, M. , Ishizuka, Y. , Yamada, H. , and Koyama, H. 1991. A study on the mechanism of antibody‐dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch. Virol. 120: 207–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kimura, T. , Ueba, N. , and Minekawa, Y. 1981. Studies on the mechanism of antibody‐mediated enhancement of Getah virus infectivity. Biken J. 24: 39–45. [PubMed] [Google Scholar]
  • 12. Nakane, P.K. , and Kawaoi, A. 1974. Peroxidase‐labeled antibody: a new method of conjugation. J. Histochem. Cytochem. 22: 1084–1091. [DOI] [PubMed] [Google Scholar]
  • 13. Olsen, C.W. , Corapi, W.V. , Ngichabe, C.K. , Baines, J.D. , and Scott, F.W. 1992. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody‐dependent enhancement of infection of feline macrophages. J. Virol. 66: 956–965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Pedersen, N.C. 1976. Morphologic and physical characteristics of feline infectious peritonitis virus and its growth in autochthonous peritoneal cell cultures. Am. J. Vet. Res. 37: 567–572. [PubMed] [Google Scholar]
  • 15. Pedersen, N.C. , and Boyle, J.F. 1980. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am. J. Vet. Res. 41: 868–876. [PubMed] [Google Scholar]
  • 16. Pedersen, N.C. , Everman, J.F. , McKeirnan, A.J. , and Ott, R.L. 1984. Pathogenicity studies of feline coronavirus isolates 79‐1146 and 79‐1683. Am. J. Vet. Res. 45: 2580–2585. [PubMed] [Google Scholar]
  • 17. Peiris, J.S.M. , and Porterfield, J.S. 1979. Antibody‐mediated enhancement of Flavivirus replication in macrophage‐like cell lines. Nature 282: 509–511. [DOI] [PubMed] [Google Scholar]
  • 18. Schlesinger, J.J. , and Brandriss, M.W. 1981. Growth of 17D yellow fever virus in a macrophage‐like cell line, U 937: role of Fc and viral receptors in antibody‐mediated infection. J. Immunol. 127: 659–665. [PubMed] [Google Scholar]
  • 19. Takeda, A. , Tuazon, C.V. , and Ennis, F.A. 1988. Antibody‐enhanced infection by HIV‐1 via Fc receptor‐mediated entry. Science 242: 580–583. [DOI] [PubMed] [Google Scholar]
  • 20. Vennema, H. , Groot, R.J. , Harbour, D.A. , Dalderup, M. , Gruffydd‐Jones, T. , Horzinek, M.C. , and Spaan, W.J.M. 1990. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 64: 1407–1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Weiss, R.C. , and Scott, F.W. 1981. Antibody‐mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 4: 175–189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Weiss, R.C. , and Scott, F.W. 1981. Pathogenesis of feline infectious peritonitis: nature and development of viremia. Am. J. Vet. Res. 42: 382–390. [PubMed] [Google Scholar]

Articles from Microbiology and Immunology are provided here courtesy of Wiley

RESOURCES